A detailed history of Covestor LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Covestor LTD holds 400 shares of BEAM stock, worth $9,796. This represents 0.01% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$9,796
Previous $9,000 11.11%
% of portfolio
0.01%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$21.22 - $32.66 $42 - $65
2 Added 0.5%
400 $9,000
Q1 2024

May 10, 2024

SELL
$23.46 - $45.07 $23 - $45
-1 Reduced 0.25%
398 $13,000
Q4 2023

Feb 09, 2024

BUY
$17.69 - $30.76 $3,927 - $6,828
222 Added 125.42%
399 $11,000
Q3 2023

Nov 13, 2023

SELL
$23.01 - $32.46 $23 - $32
-1 Reduced 0.56%
177 $4,000
Q2 2023

Aug 11, 2023

SELL
$29.32 - $35.99 $29 - $35
-1 Reduced 0.56%
178 $6,000
Q4 2022

Feb 13, 2023

BUY
$36.73 - $51.6 $2,424 - $3,405
66 Added 58.41%
179 $7,000
Q3 2022

Nov 14, 2022

BUY
$39.79 - $70.31 $4,257 - $7,523
107 Added 1783.33%
113 $5,000
Q2 2022

Aug 10, 2022

SELL
$29.86 - $62.36 $3,523 - $7,358
-118 Reduced 95.16%
6 $0
Q1 2022

May 13, 2022

BUY
$53.73 - $82.16 $2,686 - $4,108
50 Added 67.57%
124 $7,000
Q4 2021

Feb 10, 2022

BUY
$68.02 - $99.06 $5,033 - $7,330
74 New
74 $6,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.72B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.